|
Sibofimloc |
|
Escherichia |
Adherence |
Phase II trial |
Chevalier G, et al. 2021. Microbiome; Reinisch W, et al. 2022. J Gastroenterol Hepatol |
|
7-[3-methyl-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2H-isoquinolin-1-one |
Depiction based on curated SMILES
N
H
OH
OH
OH
OH
O
O
O
CH
3
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Jarvis C, et al. 2016. ChemMedChem |
|
(3R)-5-Oxo-6-(morpholinomethyl)-7-(1-naphthylmethyl)-8-phenyl-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3beta-carboxylic acid lithium salt |
Depiction based on curated SMILES
O
_
O
O
N
+
Li
N
O
H
S
|
Escherichia |
Type 1 fimbriae; P fimbriae |
Preclinical (in vivo) |
Pinkner JS, et al. 2006. Proc Natl Acad Sci U S A |
|
(3R)-5-Oxo-6-(dimethylaminomethyl)-7-(1-naphthylmethyl)-8-phenyl-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3beta-carboxylic acid lithium salt |
Depiction based on curated SMILES
_
O
N
H
3
C
N
CH
3
+
Li
O
H
S
O
|
Escherichia |
Type 1 fimbriae; P fimbriae |
Preclinical (in vivo) |
Pinkner JS, et al. 2006. Proc Natl Acad Sci U S A |
|
(3R)-5-Oxo-6-(dimethylaminomethyl)-7-methyl-8-phenyl-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3beta-carboxylic acid lithium salt |
Depiction based on curated SMILES
CH
3
H
3
C
N
_
O
O
+
Li
S
H
N
O
CH
3
|
Escherichia |
Type 1 fimbriae; P fimbriae |
Preclinical (in vivo) |
Pinkner JS, et al. 2006. Proc Natl Acad Sci U S A |
|
(3R)-5-Oxo-6-(morpholinomethyl)-7-(1-naphthylmethyl)-8-cyclopropyl-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3beta-carboxylic acid lithium salt |
Depiction based on curated SMILES
N
O
O
N
_
O
O
H
S
+
Li
|
Escherichia |
Type 1 fimbriae; P fimbriae |
Preclinical (in vivo) |
Pinkner JS, et al. 2006. Proc Natl Acad Sci U S A |
|
N-methyl-3-[3-methyl-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzamide |
Depiction based on curated SMILES
O
OH
OH
HO
HO
H
3
C
O
CH
3
O
NH
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Cusumano CK, et al. 2011. Sci Transl Med; Jarvis C, et al. 2016. ChemMedChem |
|
Carfilzomib |
Depiction based on curated SMILES
CH
3
H
3
C
N
H
O
HN
O
N
O
O
CH
3
O
O
CH
3
NH
CH
3
N
H
O
|
Streptococcus |
Adherence |
Preclinical (in vivo) |
Manzer HS, et al. 2022. PLoS Pathog |
|
ML346 |
Depiction based on curated SMILES
O
HN
O
N
H
O
CH
3
O
|
Streptococcus |
Adherence |
Preclinical (in vivo) |
Guan XN, et al. 2022. RSC Med Chem |
|
Lapatinib |
Depiction based on curated SMILES
O
N
NH
F
Cl
S
O
O
N
H
CH
3
O
N
|
Streptococcus |
Adherence |
Preclinical (in vivo) |
Manzer HS, et al. 2022. PLoS Pathog |
|
| | |